AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Understanding what a beginner investment portfolio looks like is crucial for new investors. Learn the basics to kickstart your investment journey.
27,003 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A renewed fighting spirit can power your finances forward. Learn practical steps to build resilience, cut debt, and f...
Super Micro Computer's stock has swung wildly in the AI era. This guide explains what the current valuation means, ho...
Sam Altman is driving OpenAI toward a trillion-dollar target, while SoftBank faces a substantial loan due in 2027. Th...
Two AI pioneers sit on the public markets' doorstep with wall-high expectations. This guide breaks down which giant—a...
When a stock leads the market after a big index move, investors pay attention. This piece explains why Argan stock to...
Forecasting Tesla is never dull. This article lays out base, bull, and bear scenarios for the next five years, with a...
Investors react to a key vote in the semiconductor space as IonQ jumps on the SkyWater deal. Here’s what it means for...
As Movado prepares for its Q1 2027 earnings, investors want clarity on demand, margins, and licensing deals. This gui...
As Citi gears up for its 2026 earnings call, investors need a clear view of the revenue mix, credit quality, and capi...
Agentic AI changes how data centers think and act. This guide breaks down AMD, ARM, and Intel to identify the intel: ...
A crypto exchange’s bold political donations can reshape its regulatory path and banking access. This genre of analys...